A Study of BMS-986315 and Nivolumab in Combination With Chemotherapy in Participants With First-line Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)
Clinical trial NCT06094296 · TERMINATED
Trial details
- NCT number
- NCT06094296
- Sponsor
- Bristol-Myers Squibb
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-27
- Primary completion
- 2024-08-08
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.